Ionis Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
05.10.23
/
50%
€43.75
Target price
05.10.24
€61.66
Performance (%)
-11.18%
Price
26.04.24
€38.86
Summary
This prediction is currently active. The prediction for Ionis Pharmaceuticals Inc. disappoints with a performance of -11.18%. This prediction currently runs until 05.10.24. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ionis Pharmaceuticals Inc. | 1.781% | 1.781% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Ionis Pharmaceuticals Inc. diskutieren
Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $65.00 price target on the stock.
Ratings data for IONS provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€47.43
26.01.24
26.01.24
€64.40
26.01.25
26.01.25
-18.07%
26.04.24
26.04.24
